Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2025)
Alpha Tau Medical (DRTS) reported Non Operating Income of -$867000.0 for Q4 2025, down 111.12% on a YoY basis from $7.8 million in Q4 2024, and down 189.94% sequentially from $964000.0 in Q3 2025.
Alpha Tau Medical (DRTS) Non Operating Income (2021 - 2025) Analysis & Trends
Alpha Tau Medical (DRTS) has 5 years of Non Operating Income data on file, last reported at -$867000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 111.12% year-over-year to -$867000.0; the trailing twelve-month figure through Dec 2025 stood at -$218000.0 (down 105.07% YoY), and the FY2025 full-year result was -$218000.0, down 105.07% from the prior year.
- Non Operating Income retreated to -$867000.0 in Q4 2025, from $964000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $17.0 million in Q1 2022 to a low of -$6.0 million in Q2 2022.
- A 5-year average of $1.2 million and a median of -$478000.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 328.48% in 2023 and sank 438.28% in 2024, its largest moves.
- Tracing DRTS's Non Operating Income over 5 years: stood at $9.0 million in 2021, then sank by 151.22% to -$4.6 million in 2022, then surged by 328.48% to $10.5 million in 2023, then dropped by 25.7% to $7.8 million in 2024, then slumped by 111.12% to -$867000.0 in 2025.
- Business Quant data shows DRTS's Non Operating Income at -$867000.0 in Q4 2025, $964000.0 in Q3 2025, and $401000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Alpha Tau Medical | 1.12 Bn | 1.04 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -867,000.00 |
| Sep 30, 2025 | 964,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | 7.80 Mn |
| Sep 30, 2024 | -1.37 Mn |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -444,000.00 |
| Dec 31, 2023 | 10.49 Mn |
| Sep 30, 2023 | -3.97 Mn |
| Jun 30, 2023 | 499,000.00 |
| Mar 31, 2023 | -478,000.00 |
| Dec 31, 2022 | -4.59 Mn |
| Sep 30, 2022 | -4.74 Mn |
| Jun 30, 2022 | -6.02 Mn |
| Mar 31, 2022 | 16.96 Mn |
| Mar 31, 2021 | 8.97 Mn |